🇺🇸 FDA
Patent

US 6165460

Generation of immune responses to prostate-specific antigen (PSA)

expired A61KA61K2039/5256A61K2039/55522

Quick answer

US patent 6165460 (Generation of immune responses to prostate-specific antigen (PSA)) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5256, A61K2039/55522, A61K2039/55555, A61K39/00